Literature DB >> 17182237

Inhibition of lipopolysaccharid-induced sickness behavior by a dry extract from the roots of Pelargonium sidoides (EPs 7630) in mice.

M Nöldner1, K Schötz.   

Abstract

The host response to infections comprise the synthesis and release of proinflammatory cytokines (e.g. IL-1ss, TNF-alpha, IL-6) which induce symptoms of sickness behavior characterised by anorexia, depressed activity, listlessness or malaise. In laboratory animals, sickness behavior can be induced by the administration of cytokines itself or by cytokine-inducers such as lipopolysaccharide (LPS), the active fragment of endotoxin from Gram-negative bacteria. Preparations from roots of Pelargonium sidoides have been traditionally used in South African folk medicine for the treatment of different diseases (e.g. diarrhea, dysmenorrhea, hepatic disorders and respiratory tract infections including tuberculosis). Today, aqueous ethanolic extracts of Pelargonium sidoides are marketed mainly for respiratory tract infections. We studied the effects of the extract EPs 7630 and different fractions separated by ultrafiltration in an animal model of sickness behavior. The results of this study demonstrate that the extract EPs 7630 and the high-molecular weight fraction (F3) alleviate the symptoms of sickness behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182237     DOI: 10.1016/j.phymed.2006.11.013

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  8 in total

1.  Exploring the anti-proliferative activity of Pelargonium sidoides DC with in silico target identification and network pharmacology.

Authors:  A S P Pereira; M J Bester; Z Apostolides
Journal:  Mol Divers       Date:  2017-09-18       Impact factor: 2.943

2.  Effect of Lianshu preparation on lipopolysaccharide-induced diarrhea in rats.

Authors:  Jun Liu; Rong Wan; Xuan-Fu Xu; Xing-Peng Wang; Wen-Juan Yang; Yu-Jing Xia; Hua Liu; Qian-Lin Yan; De-Xin Yan; Chuan-Yong Guo
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

Review 3.  [Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety].

Authors:  Andreas Conrad; Herbert Kolodziej; Volker Schulz
Journal:  Wien Med Wochenschr       Date:  2007

4.  Diene Valepotriates from Valeriana glechomifolia Prevent Lipopolysaccharide-Induced Sickness and Depressive-Like Behavior in Mice.

Authors:  Liz G Müller; Milene Borsoi; Eveline D Stolz; Vivian Herzfeldt; Alice F Viana; Ana Paula Ravazzolo; Stela Maris K Rates
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-11       Impact factor: 2.629

5.  Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis.

Authors:  Yanyan Bao; Yingjie Gao; Egon Koch; Xin Pan; Yahong Jin; Xiaolan Cui
Journal:  Phytomedicine       Date:  2015-03-20       Impact factor: 5.340

6.  Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.

Authors:  Jan Papies; Jackson Emanuel; Nicolas Heinemann; Žarko Kulić; Simon Schroeder; Beate Tenner; Martin D Lehner; Georg Seifert; Marcel A Müller
Journal:  Front Pharmacol       Date:  2021-10-25       Impact factor: 5.810

7.  Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis.

Authors:  W Kamin; V G Maydannik; F A Malek; M Kieser
Journal:  Acta Paediatr       Date:  2010-01-11       Impact factor: 2.299

Review 8.  Medicinal properties and conservation of Pelargonium sidoides DC.

Authors:  Mack Moyo; Johannes Van Staden
Journal:  J Ethnopharmacol       Date:  2014-01-21       Impact factor: 4.360

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.